Indinavir sulfate

This classification denotes a protease inhibitor and anti-hiv agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5W6YA9PKKH. European Medicines Agency schedules Indinavir sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02666MIG. Indinavir sulfate generally arises in the molecular formula C36H47N5O4.H2O4S. The term 'indinavir sulfate' is a European Medicines Agency European Public Assessment Report System designation. Most nations, for tariff and trade purposes, schedule indinavir sulfate under HS 29335995 and SITC 51576. As of Q4 2014, INDINAVIR SULFATE remains US FDA's Preferred Term for this commodity. Indinavir sulfate bears US NLM identifiers UMLS ID C0700483 and NCI Concept Code C1662. SMILES: CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2CCCCC2)C(=O)N[C@H]3C4CCCCC4C[C@H]3O)O)CC5CCCNC5.OS(=O)(=O)O.